Emmanuel J H J Wiertz

5PUBLICATIONS
8CO-AUTHORS
AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Industrial molecular engineering of nucleic acids and proteinsBiologically active moleculesMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 24, 2024
Proinsulin degradation and presentation of a proinsulin B-chain autoantigen involves ER-associated protein degradation (ERAD)-enzyme UBE2G2.

Tom Cremer, Hanneke Hoelen, Michael L van de Weijer

|Oct 16, 2021
A class II MHC-targeted vaccine elicits immunity against SARS-CoV-2 and its variants.

Novalia Pishesha, Thibault J Harmand, Paul W Rothlauf

|Jan 12, 2021
The UFM1 Pathway Impacts HCMV US2-Mediated Degradation of HLA Class I.

A B C Schuren, I G J Boer, E M Bouma

|Sep 03, 2020
A Broad-Spectrum Antiviral Peptide Blocks Infection of Viruses by Binding to Phosphatidylserine in the Viral Envelope.

Rutger D Luteijn, Patrique Praest, Frank Thiele

|Jul 27, 2017
Multiple E2 ubiquitin-conjugating enzymes regulate human cytomegalovirus US2-mediated immunoreceptor downregulation.

Michael L van de Weijer, Anouk B C Schuren, Dick J H van den Boomen

Pageof 1

Frequent Collaborators

3 joint publications

Robert Jan Lebbink

2 joint publications

Michael L van de Weijer

1 joint publications

Ingo Drexler

1 joint publications

Paul W Rothlauf